Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 11, 2006 11:10 ET | Source: Epigenomics AG

Epigenomics AG to Present at the 3rd Annual Rodman & Renshaw Global Healthcare Conference in Monte Carlo

BERLIN, Germany and SEATTLE, May 11, 2006 (PRIMEZONE) -- The German biotech company Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX) announced today that the company will be presenting at the 3rd...
May 03, 2006 02:23 ET | Source: Epigenomics AG

Epigenomics AG Reports First Quarter 2006 Results

BERLIN and SEATTLE, May 3, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, today reported financial...
April 05, 2006 11:10 ET | Source: Epigenomics AG

Clinical Study Proves Prognostic Power of Epigenomics' Biomarker in Prostate Cancer

BERLIN and SEATTLE, April 5, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, today presented data...
April 03, 2006 13:35 ET | Source: Epigenomics AG

Epigenomics Presents Data Confirming Screening for Methylated DNA in Blood as Key to Early Colorectal Cancer Detection

BERLIN, April 3, 2006 (PRIMEZONE) -- Epigenomics AG Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, today confirmed that...
March 24, 2006 02:09 ET | Source: Epigenomics AG

Epigenomics AG Reports Financial Results for Fiscal Year 2005

BERLIN, Germany and SEATTLE, March 24, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, today...
March 22, 2006 15:34 ET | Source: Epigenomics AG

Ad hoc: Epigenomics AG Reports Extension of Blood Screening Product Collaboration

BERLIN and SEATTLE, March 22, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Other OTC:EPGNF), a molecular diagnostics company developing tests based on DNA methylation, announced today an...
March 17, 2006 09:39 ET | Source: Epigenomics AG

Epigenomics AG to Host Press Conference and Analyst Meeting for 2005 Annual Results

BERLIN and SEATTLE, March 17, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Other OTC:EPGNF) will hold a press conference and analyst meeting on March 24, 2006 to present results for the fiscal...
January 30, 2006 02:41 ET | Source: Epigenomics AG

Epigenomics AG Pursuing Development of Tamoxifen Response Test

BERLIN and SEATTLE, Jan. 30, 2006 (PRIMEZONE) -- Epigenomics AG (Other OTC:EPGNF) (Frankfurt:ECX), a molecular diagnostics company developing tests based on DNA methylation, announced today that Roche...
January 04, 2006 03:08 ET | Source: Epigenomics AG

Epigenomics AG adds Regulatory Affairs and Marketing Expertise to Senior Management

BERLIN and SEATTLE, Jan. 4, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, announced today the...
January 04, 2006 02:11 ET | Source: Epigenomics AG

Epigenomics Successfully Completes Biomarker Validation Study for Prostate Cancer Classification Test

BERLIN and SEATTLE, Jan. 4, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, announced today the...